
Molina Healthcare (MOH) Stock Forecast & Price Target
Molina Healthcare (MOH) Analyst Ratings
Bulls say
Molina Healthcare demonstrated stronger than anticipated performance in its Medicare segment, with membership and revenue exceeding expectations, while maintaining a moderate Medical Care Ratio (MCR) of 90.0%, reflecting increased utilization in acute populations. The Medicaid segment also showed resilience, with an MCR of 91.3%, indicating year-over-year and sequential pressures primarily due to heightened utilization among both new and renewing members. Furthermore, the Marketplace segment saw historic levels of utilization growth, further supporting the overall positive outlook for Molina Healthcare’s financial health and operational strengths across its segments.
Bears say
Molina Healthcare's stock outlook is negatively impacted by a worsening trend in its marketplace segment, prompting management to provide a downward revision of guidance for fiscal year 2025. The company's second-quarter results revealed escalating medical cost pressures across all business lines, and its estimated earnings per share (EPS) for 2025 has been lowered to $14.02, significant below the previously projected adjusted EPS of no less than $19.00. Additionally, the ongoing challenges in both the Medicaid and Marketplace segments, coupled with a projected market shrinkage of over 20%, contribute to a more cautious financial outlook for the company.
This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Molina Healthcare (MOH) Analyst Forecast & Price Prediction
Start investing in Molina Healthcare (MOH)
Order type
Buy in
Order amount
Est. shares
0 shares